SCHEMBL6172977

SCHEMBL6172977

CC(c1ccncc1NC(=O)c1ccc(F)cc1)C1(C(C)c2ccncc2NC(=O)c2ccc(F)cc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 1/20 0.41
NAMPT P43490 2/20 0.40
MAPT P10636 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
ABL1 P00519 5/20 0.36
GCGR P47871 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
NTRK1 P04629 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
HSD17B13 Q7Z5P4 1/20 0.36
MTOR P42345 1/20 0.35
EGFR P00533 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175217 0.93 GAA (0.42) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174515 0.93 ALDH1A1 (0.45) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173454 0.88 CYP2C9 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172844 0.88 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174642 0.87 ALDH1A1 (0.42) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174469 0.85 TDP1 (0.42) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173479 0.85 ALDH1A1 (0.44) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174412 0.85 MAPT (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175907 0.84 ALDH1A1 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173283 0.84 CYP3A4 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed